Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P13 versus Remicade in active rheumatoid arthritis with methotrexate
2010-018646-31Phase 3Completed
- Sponsor
- Celltrion
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing CT-P13 + methotrexate with Remicade + methotrexate (2 arms). Primary endpoint: ACR20 response at Week 30. Started Jun 2010; status: completed.
02
Drugs
infliximab-dyybinfliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-018646-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018646-31.